European Medicines Agency Official Warns that Continuous COVID-19 Vaccine Boosters Could Threaten Human Health

Europe’s regulatory body known as the European Medicines Agency (EMA) held a press briefing on Tuesday, January 11 for updates on the COVID-19 pandemic. Marco Cavaleri, the EMA head of biological health threats and vaccine strategy, raised significant concerns about the present mass vaccination program implemented across the European continent. Acknowledging the highly contagious nature of the Omicron variant, the regulatory official expressed that the level of severity appears milder than the Delta variant yet emphasized the importance of further data collection for a true understanding of the unfolding Omicron epidemiological impact. Cavaleri explained that based on recent studies, vaccine effectiveness against symptomatic disease becomes significantly reduced, waning over time, and this means more fully vaccinated people in Europe become susceptible to breakthrough infections caused by either Delta or Omicron. However, the EMA official noted that with a booster, vaccine effectiveness shoots back up. Significant risks to human health manifest, however, based on the premise of a public health response driven by continuous COVID-19 vaccination booster jabs...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee